» Authors » Akash J Patel

Akash J Patel

Explore the profile of Akash J Patel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 127
Citations 2155
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mizu R, Lovin B, Coviello C, Orzaiz G, Patel A, Sweeney A
Otol Neurotol . 2025 Mar; 46(4):e130-e134. PMID: 40077843
Objective: To present a series of pediatric patients with cerebellopontine angle (CPA) lipomas in order to understand their natural history and facilitate management recommendations. Patients: Pediatric patients with a diagnosis...
2.
Rampalli I, English C, Lazaro T, Lovin B, Lee S, Huang A, et al.
Neurosurg Pract . 2025 Feb; 5(1):e00082. PMID: 39957857
Background And Importance: Bilateral vestibular schwannomas (VS) are a distinctive feature of neurofibromatosis type 2 (NF2) that result in a serious reduction in the quality of life for patients. The...
3.
Chen J, Giridharan N, Kavoussi A, Van Arsdale D, Hosseingholi Nouri S, Nitturi V, et al.
Surg Neurol Int . 2025 Feb; 16:6. PMID: 39926447
Background: Hepatocellular carcinoma (HCC) contributes significantly to global cancer-related mortality, often because patients present at advanced stages of the disease. HCC commonly metastasizes to the lung, abdominal lymph nodes, and...
4.
Patel B, Pugazenthi S, English C, Nitturi V, Pari S, Mahlokozera T, et al.
J Natl Cancer Inst . 2025 Jan; PMID: 39886924
Background: World Health Organization Grade 2 meningiomas (G2Ms) often recur and resist therapies. G2Ms with histopathological necrosis have been associated with worse local control (LC) following radiation therapy, but the...
5.
Hosseingholi Nouri S, Nitturi V, Ledbetter E, English C, Lau S, Klisch T, et al.
Cancers (Basel) . 2025 Jan; 17(1. PMID: 39796693
: With the rise in prevalence of diagnostic genetic techniques like RNA sequencing and whole exome sequencing (WES), as well as biological treatment regiments for cancer therapy, several genes have...
6.
McGinnis J, Ortiz-Guzman J, Mallannagari S, Guevara M, Belfort B, Bao S, et al.
bioRxiv . 2025 Jan; PMID: 39763930
It is becoming more broadly accepted that human-based models are needed to better understand the complexities of the human nervous system and its diseases. The recently developed human brain organotypic...
7.
Banko L, Riesenburger N, Patel R, Gilligan C, Cosgrove G, Chiocca E, et al.
Neurosurgery . 2024 Nov; PMID: 39526786
Background And Objectives: Scholarship has been critical to neurosurgery. As grades and board examinations become pass-fail, finding metrics to distinguish applicants coupled with an emphasis on research has led to...
8.
Pugazenthi S, Patel B, English C, Leidig W, McGeehan K, McCornack C, et al.
Sci Adv . 2024 Oct; 10(43):eadn4419. PMID: 39441930
An important subset of meningiomas behaves aggressively and is characterized by multiple recurrences. We identify clinical, genetic, and epigenetic predictors of multiply recurrent meningiomas (MRMs) and evaluate the evolution of...
9.
Bomsztyk K, Mar D, Denisenko O, Powell S, Vishnoi M, Yin Z, et al.
Lab Invest . 2024 Oct; 104(12):102160. PMID: 39426568
Precision oncology is driven by biomarkers. For glioblastoma multiforme (GBM), the most common malignant adult primary brain tumor, O-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation is an important prognostic and treatment...
10.
Nguyen M, Morshed R, Youngblood M, Perlow H, Lucas C, Patel A, et al.
Neuro Oncol . 2024 Sep; 27(2):445-454. PMID: 39340366
Background: Despite reassuring clinical and histological features, low-grade meningiomas can recur after surgery. Targeted gene expression profiling improves risk stratification of meningiomas, but the utility of this approach for clinical...